Related Experiment Video
Updated: Jun 12, 2025

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Severe Pneumonia and Cytomegalovirus Coinfection in Infants with Human Immunodeficiency Virus Infection
Wonashi R Tsanglao1, Maitreyee Joshi2, Tenukala Aier1
1Consultant, MD Pediatrics, Department of Pediatrics, Christian Institute of Health Sciences and Research, Dimapur, Nagaland, India.
Insights
Cytomegalovirus (CMV) causes fatal pneumonia in children with human immunodeficiency virus (HIV). Early detection and care are crucial for infants with HIV and suspected CMV coinfection, especially in India.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Cytomegalovirus (CMV) is a known cause of fatal pneumonia in children with human immunodeficiency virus (HIV).
- Limited literature exists on pediatric HIV and CMV coinfection in India.
- Severe pneumonia presents a significant mortality risk in HIV-infected infants.
Purpose of the Study:
- To describe cases of severe pneumonia in infants with HIV in India.
- To investigate the role of Cytomegalovirus (CMV) coinfection in these cases.
- To highlight the importance of antenatal and postnatal care for HIV-positive mothers and their infants.
Main Methods:
- Retrospective case series of six infants with HIV presenting with severe pneumonia.
- Detection of CMV coinfection using urine polymerase chain reaction (PCR).
- Review of antenatal and postnatal care access for all cases.
Main Results:
- Four out of six infants with HIV had confirmed CMV coinfection.
- All four infants with CMV coinfection died from severe acute respiratory distress syndrome (ARDS).
- The two infants without CMV coinfection survived.
Conclusions:
- A high index of suspicion for CMV is warranted in HIV-infected infants with severe pneumonia.
- CMV pneumonia diagnosis in this population can be challenging.
- Antenatal and postnatal care are critical for managing HIV and preventing opportunistic infections like CMV in infants.
Summary:
Cytomegalovirus (CMV) is known to cause fatal pneumonia in human immunodeficiency virus (HIV) infected children. There is a paucity of literature on pediatric HIV and CMV coinfection in India. We describe six cases of severe pneumonia in infants infected with HIV. Four of these infants also had CMV coinfection, detected by urine polymerase chain reaction. There was a lack of antenatal and postnatal care in all cases. All four infants with CMV coinfection succumbed to severe acute respiratory distress syndrome, whereas the other two survived. In conclusion, a high index of suspicion for CMV should be kept in HIV-infected infants presenting with severe pneumonia, although CMV pneumonia is difficult to diagnose with certainty. The important role of antenatal care for mothers with HIV infection, as well as postnatal care for babies born to HIV-positive mothers, cannot be overstated.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology